Epigenetics in psoriasis: perspective of DNA methylation

Mol Genet Genomics. 2021 Sep;296(5):1027-1040. doi: 10.1007/s00438-021-01804-y. Epub 2021 Jun 17.

Abstract

Psoriasis is a chronic inflammatory skin disease characterized by excessive proliferation of keratinocytes (KCs). Onset of psoriasis is related to genetic, immune and environmental factors. The environment can interact with the genome through epigenetic modifications, including DNA methylation, and this modification is involved in the pathogenesis of psoriasis. In addition to a skin disease, psoriasis is also considered a systemic disease. We reviewed the current literature of psoriatic DNA methylation for studies from several aspects on the DNA methylation distribution patterns in different tissues/cells, single-nucleotide polymorphisms, and candidate disease genes and identified target genes regulated by DNA methylation that have been directly/indirectly validated. This review contributes to a comprehensive understanding of the important a role that DNA methylation plays in psoriasis from a holistic perspective and will promote the implementation of DNA methylation in diagnostic and therapeutic strategies for psoriatic patients.

Keywords: DNA methylation; Epigenetic; Psoriasis; Research progress; Sequencing.

Publication types

  • Review

MeSH terms

  • CD4-Positive T-Lymphocytes / physiology
  • DNA Methylation*
  • Epigenesis, Genetic*
  • Genome-Wide Association Study
  • Humans
  • Leukocytes, Mononuclear / physiology
  • Polymorphism, Single Nucleotide*
  • Psoriasis / genetics*
  • Psoriasis / pathology